NFKB1 and breast carcinoma: Moreover, a mechanistic study revealed that ADAM9 promotes the progression of MDA-MB-231 breast cancer cells by activating the AKT/NF-κB pathway [188], an oncogenic signaling pathway implicated in many cancers [194].